The Metabolomics Advanced Services Core combines capabilities for metabolomic data analysis from six metabolic laboratories located at UC Davis: the Fiehn Genome Center metabolomics laboratory (primary metabolism and complex lipids), the Hammock NIEHS superfund laboratory (eicosanoids and vitamins), the Lebrilla mass spectrometry laboratory (glycans), the Newman WHNCR laboratory (lipid mediators), the Cherry laboratory (imaging) and the Gaikwad laboratory (steroids). These methods will be available for service in Pilot &Feasibility studies and through recharge-rate fee structures. The laboratories will further advance and expand these methods for cross-platform integrated metabolomic studies. All services will be promoted by the Administrative Core, with samples to be delivered through the Central Service Core and managed by the centralized LIMS software. Advanced methods that have been automated and validated to be applicable for fast, high-quality operation will be transferred to the Central Service Core to accelerate throughput and turnaround times for regional and national clients. The Advanced Services laboratories will help with metabolomics training and pilot projects administered by the Promotion &Outreach Core. The core will provide comprehensive capabilities for metabolomic studies. Faculty and staff will collaborate with regional scientists in study design, implementation and data interpretation of metabolomic projects in clinical and preclinical studies. The core will expand the scope of its current quantification capabilities of 1,069 identified metabolite targets. Using untargeted metabolomics, the core will provide discovery services that extend to novel metabolic intermediates, followed by subsequent structural annotations and validation measurements. Secondly, the Core will advance metabolomics services and transfer methods to the Central Service Core. Scientists will develop or adapt methods to accelerate sample preparation processes by automating liquid- and solid-phase handling steps using a robotic sample handling device. Data processing steps will be optimized, and final methods will be transferred to the Central Service Core for the most robustly quantifiable sets of target metabolites. Isotope-based flux analyses will be implemented and transferred to the Central Service Core on GC-MS basis. For untargeted metabolomics, generalized retention-index marker compounds will be used to enable alignment procedures across different matrices. Image-guided mass spectrometry will open a novel field in metabolomics using fluorescently labeled metabolites and drugs for spatially targeting metabolically active zones in tissues and cell types.

Public Health Relevance

Comprehensive analysis of metabolism is critical to understand diseases such as diabetes, heart attack and stroke, or growth and progression of cancerous tumors. Development and advancement of tools enabling to establish holistic views onto bodily and cellular metabolism will help achieving this goal. The aim is to advance science and technology as well make metabolomic tools available to clinical and preclinical scientists.

Project Start
Project End
Budget Start
2014-09-01
Budget End
2015-08-31
Support Year
3
Fiscal Year
2014
Total Cost
Indirect Cost
Name
University of California Davis
Department
Type
DUNS #
City
Davis
State
CA
Country
United States
Zip Code
95618
Arabyan, Narine; Huang, Bihua C; Weimer, Bart C (2017) Draft Genome Sequences of Salmonella Lysozyme Gene Knockout Mutants. Genome Announc 5:
Zhang, Jie; Light, Alan R; Hoppel, Charles L et al. (2017) Acylcarnitines as markers of exercise-associated fuel partitioning, xenometabolism, and potential signals to muscle afferent neurons. Exp Physiol 102:48-69
Flitter, Becca A; Hvorecny, Kelli L; Ono, Emiko et al. (2017) Pseudomonas aeruginosa sabotages the generation of host proresolving lipid mediators. Proc Natl Acad Sci U S A 114:136-141
Wan, Debin; Yang, Jun; Barnych, Bogdan et al. (2017) A new sensitive LC/MS/MS analysis of vitamin D metabolites using a click derivatization reagent, 2-nitrosopyridine. J Lipid Res 58:798-808
Fong, Louise Y; Jing, Ruiyan; Smalley, Karl J et al. (2017) Integration of metabolomics, transcriptomics, and microRNA expression profiling reveals a miR-143-HK2-glucose network underlying zinc-deficiency-associated esophageal neoplasia. Oncotarget 8:81910-81925
Jonscher, Karen R; Stewart, Michael S; Alfonso-Garcia, Alba et al. (2017) Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J 31:1434-1448
Barnych, Bogdan; Rand, Amy A; Cajka, Tomas et al. (2017) Synthesis of cyclooxygenase metabolites of 8,9-epoxyeicosatrienoic acid (EET): 11- and 15-hydroxy 8,9-EETs. Org Biomol Chem 15:4308-4313
Tu, Lan N; Showalter, Megan R; Cajka, Tomas et al. (2017) Metabolomic characteristics of cholesterol-induced non-obese nonalcoholic fatty liver disease in mice. Sci Rep 7:6120
Blaženovi?, Ivana; Kind, Tobias; Torbašinovi?, Hrvoje et al. (2017) Comprehensive comparison of in silico MS/MS fragmentation tools of the CASMI contest: database boosting is needed to achieve 93% accuracy. J Cheminform 9:32
Agrawal, Karan; Waller, Justin D; Pedersen, Theresa L et al. (2017) Effects of stimulation technique, anatomical region, and time on human sweat lipid mediator profiles. Prostaglandins Other Lipid Mediat :

Showing the most recent 10 out of 148 publications